Yep. Cut losses or we still believe? I was up big on this but now it's a small winnerOPES, LCA, FMCI all taking a dump.
Man I first read that number as $100KBought another $1000.00 worth of CYDY at $6.10 during the slide today. My first purchase of the stock over $2. Was going to put the 1k into something else like Delta or Disney but still feel the upside for CYDY at ~$6 is worth the risk vs return I get in the others.
Todem recommended it. Seems to be a stable utility, nice dividend. Utilities have been whacked lately, which is opposite of what normally happens - they're usually the port in a storm. But since they're dipping a bit seems a good time to pick off one or two of them.Why do you like them in particular? Just the dividend? I've been slowly adding some utilities.
Most recent info i could find.Can someone find out what he is owed and what he currently owns? Should be public information.
What about the price points?Larger intraday trades settling, I think
I wriggled out of TZA with a 3.4% return.Will revisit a little closer to earnings season.
I sold at the bell for a 3.4% return.
Something is wrong because my bid ask is 5.93 but my main page on schwab says it closed at 6.99 and that I’m upWhat about the price points?
Same with Schwab. That's actually why I went and checked the after hours quotes.Something is wrong because my bid ask is 5.93 but my main page on schwab says it closed at 6.99 and that I’m up
The same share amounts are traded 3 times. So my guess is that a trade was accidentally entered wrong at $6.99 instead of $6.09. So they did a second trade at $6.99 to reverse it. And then put the real trade in at $6.09.https://i.imgur.com/mqmaG1C.png
Like, wtf is going on with this stock? This seems like some shady ####.
lol 600k shares? you dont fat finger price on 600k sharesThe same share amounts are traded 3 times. So my guess is that a trade was accidentally entered wrong at $6.99 instead of $6.09. So they then reversed the trade at $6.99. And put the real trade in at $6.09.
CytoDyn’s Leronlimab Prevents Transmission of SHIV in Macaque Study
July 07, 2020 5:02pm EDT
https://www.cytodyn.com/newsroom/press-releases/detail/446/cytodyns-leronlimab-prevents-transmission-of-shiv-in
Results of preclinical study presented today in oral presentation at the 23rd International AIDS Conference (AIDS 2020)
VANCOUVER, Washington, July 07, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential clinical indications for HIV, COVID-19, cancer, GvHD and NASH announced today the results from a preclinical macaque study evaluating leronlimab as pre-exposure prophylaxis (PrEP) to prevent sexual HIV transmission. The study evaluated the impact of a macaque-equivalent dose of either 350 mg (once weekly) or 700 mg (bi-monthly) leronlimab on acquisition of infection in a total of 18 animals, and found that the equivalent 700 mg bi-monthly leronlimab dose completely prevented rectal transmission of Simian-Human Immunodeficiency Virus (SHIV) in macaques. These results were presented today in an oral presentation titled “CCR5 antibody blockade protects rhesus macaques from rectal SHIV acquisition" at the 23rd International AIDS Conference (AIDS 2020).
“The results reported here in the preclinical macaque model of HIV sexual transmission support leronlimab as a possible PrEP agent at a time when long-acting human HIV PrEP options are limited,” said Dr. Jonah Sacha, Professor at Oregon Health & Science University, and the study’s lead investigator.
“We are eager to build upon these preclinical results describing leronlimab’s utility in HIV prevention by initiating clinical studies for leronlimab as a PrEP treatment. Current PrEP options require a continued daily dosing regimen in order to be effective and are inherently difficult to maintain in the long-term,” said Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn. “Coupled with its safety profile, leronlimab could offer a much needed simple and long-lasting preventative treatment option for people at risk of HIV infection,” concluded Dr. Pourhassan.
Covid?? No. Pretty sure no. But maybe. But not likely.So leronlimab might be able to be used as prophylaxis to prevent HIV and Covid infections? I remember Bruce Patterson saying awhile ago that no one in the HIV trials had become infected with Covid. I wonder if that is still true?
Someone on the yahoo finance board said they called Morgan Stanley and they confirmed that it was indeed a fat finger.lol 600k shares? you dont fat finger price on 600k shares
weird ####
Saying I am fairly certain that leronlimab, as great as it may be, will not prevent you from getting Covid.
How would you explain the fact that no HIV users have contracted the virus?Saying I am fairly certain that leronlimab, as great as it may be, will not prevent you from getting Covid.
Sample size. Are they testing for it (asymptomatic)?How would you explain the fact that no HIV users have contracted the virus?
possiblySample size.
Yea, I added that.possibly
or maybe they actually contracted it, but the symptoms were so minimal it was not diagnosed?
yeah, who knows. I have no idea if the no COVID cases in that sample is even accurate. Its the internet. I speculateYea, I added that.
Are they testing for it? Asymptomatic?
Maybe HIV kills it. Lets infect everyone with HIV, problem solved.How would you explain the fact that no HIV users have contracted the virus?
eta- if true, I see no other explanation
How'd you end up on this? I might have missed a few of the points inbetween.Finally bailed on the majority of my NKLA. Just brutal. Expect it to moon tomorrow.
Still in!
Very small profit (at least relative to where it once sat). Had 915 warrants at a cost basis of $18.8. Ended up selling at $20.16. They were as high as $41.How'd you end up on this? I might have missed a few of the points inbetween.
Leverage on sqqq?Still in!
TZA: +2.3%
SQQQ: - 1.9%
IMO when QQQ turns we're looking at ~15-20% quickly. Maybe more.
Need a solvency crisis + liquidity 2.0 crisis for that to happen, but if it does it will be wicked.Still in!
TZA: +2.3%
SQQQ: - 1.9%
IMO when QQQ turns we're looking at ~15-20% quickly. Maybe more.
With you on this one.Been Gone 10 years or so. So I missed the CYDY fun. Havnt been doing much stocks but...
Old position im down in CRON. Like the day after I bought some company invested 12 billion in them. Tripled up, but I was hanging on for the grandslam. still holding 250 shares at $7.94.
Just purchased...
CHWY - I just believe in the company and think maybe amazon buys them someday. 250 shares @ $45.80
BRPHF - flyer 4000 shares @ 1.27
Been Gone 10 years or so. So I missed the CYDY fun. Havnt been doing much stocks but...
Old position im down in CRON. Like the day after I bought some company invested 12 billion in them. Tripled up, but I was hanging on for the grandslam. still holding 250 shares at $7.94.
Just purchased...
CHWY - I just believe in the company and think maybe amazon buys them someday. 250 shares @ $45.80
BRPHF - flyer 4000 shares @ 1.27
With you on this one.
That's what you get for going to Seaside.I had two choices on Friday afternoon at 3pm in Seaside, OR: Doc or Snooks. Those were the two. And when I called Snooks and listened to his rambling VM message about how the Covid has caused all sorts of ruckus to his business, I decided to give Doc the business.
Moral of the story is, don't have a family.
Looking at some long term charts that indicate a price of $80,000/share in 2004.Jokes abound but my buddy is pushing buying LODE
They’re stonks. And you just HODL.Hi I’m new here, you guys trading stocks or what?
Quicken Loans just filed IPO paperwork. No date or price available yet.Any upcoming IPO's that have anyone ready to jump in? Seems like quite a few of late have had big opening days.
I'm in the industry and heard that they got CRUSHED with margin calls in April. Though Quicken does a lot of loans, they don't seem to have a ton of repeat business because their loan officers for the most part are terrible and they have stupid high fees. They do a lot of wholesale business as well though.Quicken Loans just filed IPO paperwork. No date or price available yet.